Author Correction: TGF-β promotes pericyte–myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways
Zhenzhen Zhao, Yumeng Zhang, Chaoyang Zhang, Jingting Zhang, Xueting Luo, Qinghua Qiu, Dawei Luo, Jingfa Zhang · 2026
Read Author Correction: TGF-β promotes pericyte–myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways by Zhenzhen Zhao, Yumeng Zhang, Chaoyang Zhang, Jingting Zhang, Xueting Luo, Qinghua Qiu, Dawei Luo, Jingfa Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13324135.txt.
Description
Zhenzhen Zhao and team issued a correction to their earlier paper on how TGF-beta drives pericyte-to-myofibroblast transition in subretinal fibrosis through the Smad2/3 and Akt/mTOR pathways. The 2026 notice, published in Experimental and Molecular Medicine, addresses a single figure error in the original 2022 article. It states plainly what went wrong and what was fixed, without revising any of the paper's claims.
In Figure 4c, the fibronectin staining image for the rapamycin-treated group had been replaced by mistake with a duplicate of the DMSO control image. The corrected version restores the proper original image for that panel. The authors stress that the fix concerns representative illustration only and leaves all data analyses, results, interpretations, and conclusions untouched. Readers should therefore treat the original findings as unchanged, with only the figure panel corrected.
Catalog record
| CREATOR | Zhenzhen Zhao, Yumeng Zhang, Chaoyang Zhang, Jingting Zhang, Xueting Luo, Qinghua Qiu, Dawei Luo, Jingfa Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 909 bytes |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |